| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Neisseria porin proteins
2
relevant articles (1 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: a major protein with limited antigenic viability; two main subtypes PIA and PIB and nine main serotypes have been described; amino acid sequence given in FEMS Microbiol Lett 1991;67(2):179-86
Also Known As:porin proteins, Neisseria; PorA protein, Meningococcus; PorA protein, Neisseria gonorrhoeae; PorA protein, Neisseria meningitidis; PorB protein, Neisseria gonorrhoeae; PorB protein, Neisseria meningitidis; class I outer membrane protein, meningococcal; gonococcal OMP protein IA; gonococcal outer membrane protein I; gonococcal outer membrane protein IA; gonococcal outer membrane protein IB; gonococcal porin; gonococcal porin A; gonococcal porin B; gonococcal protein I; major outer membrane protein P.IA, Neisseria gonorrhoeae; major outer membrane protein P.IA, Neisseria meningitidis; major outer membrane protein P.IB, Neisseria gonorrhoeae; major outer membrane protein P.IB, Neisseria meningitidis; porA protein, meningococcal; porin Ib, Neisseria gonorrhoeae; porin PIA, N. gonorrhoeae; porin PIB, N. gonorrhoeae; protein I, Neisseria gonorrhoeae
Related Diseases
| 1. | Infection
06/01/1986
- "Several monoclonal antibodies directed against gonococcal outer membrane protein IB have been used in in vitro assays to investigate their potential efficacy in protection against gonococcal infection. "
Order ALL the reference details at left... |
| 2. | Blister (Bulla)
09/01/1992
- "Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants."
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Monoclonal Antibodies
|
| 2. | Liposomes (Liposome)
|
Best Treatments:
Research Summary Report
on Infection
Research Summary Report
on Infection
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 14726 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |